Here are five things to know:
1. Ms. Stryker sold 12,000 shares on July 17. She disclosed the insider selling transaction on July 21 to the Securities and Stock Exchange.
2. The shares were sold at $98.03 per share for a total value of $1.1 million.
3. Stryker shares rose 2.81 percent in the past week and 3.7 percent in the last four weeks.
4. S&P 500 gave the stock an outperform rating last week by 5.13 percent. The outperformance increased to 4.82 percent for the past four weeks.
5. Stryker has a consensus “buy” rating and after trading began this past Friday the stock hit $103.83, ending the day at $100.97. The market cap is $38 billion.
More articles on orthopedic devices:
Stryker earnings skyrocket 206%: 10 key notes on 2Q
Intelligent Implant Systems closes funding round for spine system
Nevro selects Coastal Orthopedics for clinical trial
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
